Co-Authors
This is a "connection" page, showing publications co-authored by Takaji Wakita and Yoshiki Koizumi.
Connection Strength
0.473
-
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study. PLoS Med. 2021 07; 18(7):e1003660.
Score: 0.239
-
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment. iScience. 2021 Apr 23; 24(4):102367.
Score: 0.234